TENET HEALTHCARE CORP - Common Stock (THC) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
THC on NYSE
Shares outstanding
95,358,080
Price per share
$198.72
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
46,895,161
Total reported value
$9,321,072,026
% of total 13F portfolios
0.01%
Share change
+669,765
Value change
+$125,702,424
Number of holders
542
Price from insider filings
$198.72
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TENET HEALTHCARE CORP - Common Stock (THC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.8% $1,024,603,493 8,391,511 BlackRock, Inc. 31 Mar 2025
Invesco Ltd. 4.4% $509,469,088 4,172,556 Invesco Ltd. 31 Mar 2025

As of 31 Dec 2025, 542 institutional investors reported holding 46,895,161 shares of TENET HEALTHCARE CORP - Common Stock (THC). This represents 49% of the company’s total 95,358,080 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of TENET HEALTHCARE CORP - Common Stock (THC) together control 57% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 9.3% 8,856,018 -1.7% 0.03% $1,759,867,896
BlackRock, Inc. 9% 8,535,892 -0.12% 0.03% $1,696,252,460
FMR LLC 8% 7,642,182 -3.4% 0.08% $1,518,654,423
PRICE T ROWE ASSOCIATES INC /MD/ 7.9% 7,490,350 +1.6% 0.16% $1,488,484,000
Boston Partners 3.8% 3,642,136 +16% 0.75% $723,804,310
STATE STREET CORP 2.8% 2,693,391 -1.4% 0.02% $535,230,660
AMERIPRISE FINANCIAL INC 1.8% 1,738,959 -5.3% 0.08% $345,568,365
GEODE CAPITAL MANAGEMENT, LLC 1.8% 1,723,563 -3.1% 0.02% $342,575,314
DIMENSIONAL FUND ADVISORS LP 1.3% 1,275,779 -4.2% 0.05% $253,540,559
NORGES BANK 1.3% 1,250,473 0.03% $248,493,995
Nuveen, LLC 1.2% 1,155,677 +12% 0.06% $229,656,134
WELLINGTON MANAGEMENT GROUP LLP 1.2% 1,135,801 +1114% 0.04% $225,706,374
Allianz Asset Management GmbH 0.91% 868,134 +78% 0.2% $172,515,587
MORGAN STANLEY 0.88% 840,693 +5.8% 0.01% $167,063,023
NORTHERN TRUST CORP 0.81% 770,443 -3.8% 0.02% $153,102,433
VICTORY CAPITAL MANAGEMENT INC 0.77% 731,575 +19% 0.08% $145,378,584
Bank of New York Mellon Corp 0.68% 646,397 -10% 0.02% $128,451,941
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.66% 634,072 -0.16% 0.02% $126,002,788
UBS Group AG 0.47% 444,066 -9.7% 0.02% $88,244,796
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.45% 426,799 +15% 0.05% $84,813,497
JPMORGAN CHASE & CO 0.44% 422,868 +2.6% 0.01% $84,032,330
WCM INVESTMENT MANAGEMENT, LLC 0.42% 400,968 -21% 0.17% $80,714,858
FARALLON CAPITAL MANAGEMENT LLC 0.39% 372,153 -10% 0.43% $73,954,244
CITIGROUP INC 0.38% 361,188 -2.3% 0.05% $71,775,279
BW Gestao de Investimentos Ltda. 0.37% 357,435 -14% 2.5% $71,029,483

Institutional Holders of TENET HEALTHCARE CORP - Common Stock (THC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 46,895,161 $9,321,072,026 +$125,702,424 $198.72 542
2025 Q3 83,537,642 $16,958,963,615 -$547,759,490 $203.04 671
2025 Q2 86,705,205 $15,256,042,920 -$242,114,800 $176.00 619
2025 Q1 88,102,608 $11,848,580,868 -$297,990,635 $134.50 557
2024 Q4 90,782,644 $11,460,937,238 +$74,973,470 $126.23 571
2024 Q3 88,853,987 $14,755,648,870 -$388,930,023 $166.20 596
2024 Q2 92,054,252 $12,246,548,506 -$231,494,763 $133.03 522
2024 Q1 93,979,649 $9,878,072,066 +$21,023,735 $105.11 448
2023 Q4 95,052,239 $7,183,420,124 -$61,999,835 $75.57 420
2023 Q3 96,023,570 $6,326,878,906 -$70,153,915 $65.89 405
2023 Q2 95,766,096 $7,793,537,068 -$238,287,442 $81.38 410
2023 Q1 99,389,967 $5,903,975,587 -$260,800,223 $59.42 359
2022 Q4 104,685,581 $5,107,056,484 -$189,448,183 $48.79 349
2022 Q3 107,996,779 $5,568,387,416 +$91,465,890 $51.58 346
2022 Q2 105,740,110 $5,559,583,262 -$63,755,091 $52.56 347
2022 Q1 105,282,868 $9,052,535,353 +$282,827,156 $85.96 388
2021 Q4 102,521,862 $8,374,229,051 +$119,235,986 $81.69 361
2021 Q3 100,968,332 $6,709,151,477 +$55,798,127 $66.44 326
2021 Q2 100,293,045 $6,718,584,522 +$246,651,010 $66.99 314
2021 Q1 97,408,920 $5,065,644,752 -$60,322,413 $52.00 299
2020 Q4 99,122,344 $3,958,107,321 -$64,323,227 $39.93 264
2020 Q3 102,234,584 $2,504,131,936 +$7,053,786 $24.51 234
2020 Q2 102,228,001 $1,850,912,849 +$1,244,953 $18.11 224
2020 Q1 104,884,711 $1,510,464,449 -$62,618,800 $14.40 240
2019 Q4 103,527,921 $3,934,674,864 -$213,112,670 $38.03 256
2019 Q3 109,824,690 $2,428,280,890 +$92,511,192 $22.12 235
2019 Q2 105,979,797 $2,185,403,553 +$35,545,953 $20.66 235
2019 Q1 103,605,019 $2,986,181,928 +$15,127,630 $28.84 251
2018 Q4 104,460,437 $1,789,770,177 -$126,837,659 $17.14 254
2018 Q3 108,937,826 $3,099,894,673 +$63,271,498 $28.46 250
2018 Q2 106,334,815 $3,569,754,759 -$165,762,173 $33.57 242
2018 Q1 112,004,501 $2,716,128,701 -$112,384,909 $24.25 227
2017 Q4 120,099,329 $1,820,709,170 -$113,671,487 $15.16 223
2017 Q3 127,841,674 $2,100,033,634 +$145,149,848 $16.43 233
2017 Q2 117,323,436 $2,268,906,016 +$91,431,122 $19.34 234
2017 Q1 113,160,326 $2,003,985,108 +$458,866,205 $17.71 241
2016 Q4 101,576,997 $1,507,446,454 +$4,383,004 $14.84 247
2016 Q3 99,036,234 $2,242,080,002 -$49,420,243 $22.66 253
2016 Q2 100,077,533 $2,766,065,984 -$40,378,140 $27.64 249
2016 Q1 101,442,845 $2,934,194,257 -$50,722,671 $28.93 261
2015 Q4 102,781,234 $3,113,900,998 -$26,532,051 $30.30 268
2015 Q3 101,393,770 $3,743,094,540 +$37,675,701 $36.92 303
2015 Q2 98,165,333 $5,680,747,480 +$36,900,177 $57.88 327
2015 Q1 98,167,318 $4,857,964,129 +$154,125,547 $49.51 303
2014 Q4 95,006,721 $4,811,470,511 -$57,730,542 $50.67 313
2014 Q3 95,528,364 $5,673,545,364 -$56,755,342 $59.39 306
2014 Q2 97,262,068 $4,565,394,023 +$16,257,278 $46.94 284
2014 Q1 98,620,050 $4,221,007,463 +$260,249,863 $42.81 282